VOYA Investment Management
BPMC

VOYA Investment Management’s Blueprint Medicines BPMC Stock Holding History

VOYA Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-102,552
Closed -$13.1M – 2467
2025
Q2 		$13.1M Sell
102,552
-139,120
-58% -$14.4M 0.01% 656
2025
Q1 		$21.4M Buy
241,672
+36,281
+18% +$3.54M 0.02% 497
2024
Q4 		$17.9M Buy
205,391
+21,640
+12% +$1.98M 0.02% 577
2024
Q3 		$17M Buy
183,751
+6,118
+3% +$608K 0.02% 601
2024
Q2 		$19.1M Buy
177,633
+70,454
+66% +$7.05M 0.02% 558
2024
Q1 		$10.2M Buy
107,179
+992
+0.9% +$85.1K 0.01% 748
2023
Q4 		$9.79M Sell
106,187
-53,595
-34% -$3.47M 0.01% 752
2023
Q3 		$8.02M Sell
159,782
-328
-0.2% -$17.5K 0.01% 783
2023
Q2 		$10.1M Buy
160,110
+47,971
+43% +$2.61M 0.01% 730
2023
Q1 		$5.05M Sell
112,139
-135
-0.1% -$6.08K 0.01% 984
2022
Q4 		$4.92M Sell
112,274
-485
-0.4% -$23.3K 0.01% 971
2022
Q3 		$7.43M Buy
112,759
+31,604
+39% +$2.03M 0.01% 810
2022
Q2 		$4.1M Sell
81,155
-35,289
-30% -$2.07M 0.01% 816
2022
Q1 		$7.44M Buy
116,444
+44,382
+62% +$3.19M 0.02% 719
2021
Q4 		$7.72M Sell
72,062
-82,687
-53% -$8.65M 0.01% 696
2021
Q3 		$15.9M Buy
154,749
+31,911
+26% +$2.97M 0.03% 411
2021
Q2 		$10.8M Sell
122,838
-25,022
-17% -$2.29M 0.02% 580
2021
Q1 		$14.4M Sell
147,860
-21,257
-13% -$2.12M 0.03% 452
2020
Q4 		$19M Sell
169,117
-50,456
-23% -$5.32M 0.04% 363
2020
Q3 		$20.4M Buy
219,573
+22,223
+11% +$1.71M 0.05% 324
2020
Q2 		$15.4M Sell
197,350
-44,505
-18% -$3.01M 0.04% 401
2020
Q1 		$14.1M Sell
241,855
-9,851
-4% -$634K 0.04% 382
2019
Q4 		$20.2M Sell
251,706
-95,794
-28% -$7.17M 0.04% 372
2019
Q3 		$25.5M Buy
347,500
+98,836
+40% +$8.54M 0.06% 312
2019
Q2 		$23.5M Sell
248,664
-81,321
-25% -$6.71M 0.05% 346
2019
Q1 		$26.4M Sell
329,985
-51,047
-13% -$3.77M 0.06% 295
2018
Q4 		$20.5M Sell
381,032
-83,896
-18% -$5.1M 0.05% 346
2018
Q3 		$36.3M Buy
464,928
+28,034
+6% +$1.95M 0.07% 270
2018
Q2 		$27.7M Buy
436,894
+119,406
+38% +$9.5M 0.06% 351
2018
Q1 		$29.1M Buy
317,488
+298,594
+1,580% +$25.7M 0.06% 314
2017
Q4 		$1.43M Buy
18,894
+700
+4% +$49.3K ﹤0.01% 1215
2017
Q3 		$1.27M Hold
18,194
– – ﹤0.01% 1263
2017
Q2 		$922K Buy
18,194
+8,734
+92% +$371K ﹤0.01% 1446
2017
Q1 		$378K Hold
9,460
– – ﹤0.01% 1896
2016
Q4 		$265K Hold
9,460
– – ﹤0.01% 2139
2016
Q3 		$281 Buy
+9,460
New +$235K ﹤0.01% 2078

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

VOYA Investment Management's BPMC Position: Q3 2025 in Review

VOYA Investment Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 102,552 shares — an estimated $13.1M sold.

VOYA Investment Management first reported a position in BPMC in Q3 2016 and held it in 36 quarters. The position peaked at $36.3M in Q3 2018. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • VOYA Investment Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 102,552 Blueprint Medicines shares in Q3 2025, an estimated $13.1M.
  • VOYA Investment Management first reported a position in Blueprint Medicines in Q3 2016 and held it in 36 quarters.
  • VOYA Investment Management's Blueprint Medicines position peaked at $36.3M in Q3 2018.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.